 

UUID : 48DBS726-833D-467C~85F2-95EF53984D5E

WISllfllAllpllllllllllIlllllllﬁfnlllllted

|||||||||||||||||||||||||||| II II

|||||l|||||||||||ll||||||l|||||||||||||||||||||||||||||||||||||| f . rammed » _J
IHIIIIIIIl||||||||||||||||||||||||||||||||||||||||||||||||||||| , ge- --

icb—O ~b
W S 0.01,.«5
tuw- Aggie-(Amy) 3070/3

em} 5‘46”“), Nos cb’l. “l

Clinical Case Report

Tumorslte

 

 

M)
{1970’ [Informed Consenli

I personally informed this patient that a specimen(s) would be collected to be used for research
purposes. 1 reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT
FORM with the patient and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of this informed consent document will be retained at

 

our institution.
Name of Physician or Study Coordinator - Signature I ’ Date

 

Qinical Information]

Data of Birth (mm/dd/ww) Marital Race

\r
m

Gender _ _ aloud Pressure Heart Rate
Cl Male emale

 

 

 

5.1,: 1% HISTORYOFPRESENTILLNESS‘L iii-‘11? if}: f"’x.-‘:fi';i:f=:i+559???
Chief Complaints: Mmmﬁti 1709f?) rm;— beam-A {M We. MW

symptoms: HewaﬁLA; (7\ l‘ \NQ/‘LW Lag

Clinical Findings:

 

 

 

 

 

Performance Scale (Karnofsky Score):
El 100 Asymptomatic :1 80-90 Symptomatic but Fully Ambulatory CI 60-70 Symptomatic, in bed less than 50% of day

340-50 Simptomatic, in bed more than 50% of day. but not bed ridden a 20-30 Bed Ridden
u

 

 

 

CURREN'F'MEDICATIONS r..-.

Dose Route Date
I

/
/
/
/

 

,, -'-=’PAST MEDICAL HISTORY???xiv... . . - _
Treatment Status

Disease Disorder Date

 

  

 

 
        

 

   

 

 

 

 

 

 

 

. . . ; OBlG-YNIHISTORY . . , , .
Menopausal Status Date of First Menses J # of Premancies
D Pre-menopausal : E e :I:&_ :Q g i
E] Peri—Menopausal Date of La Menses # of Live Bllths
$Post-menopausal \csean/K he? 0,]
r Birth Control: Cl Condom u Oral ContraceptiveI fa IUD . Cl Hormone Replacement
D Other: The-mum“

 

R .
Environmental Hazards:
Smoki H
Current Status Packs Duration
1:] YES - N0

Alcohol Consum
TYPE
V D YES

Use
Current Status

D YES

Relative

 

 

       

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LABDATA,‘
Test Result l Date trail Test Result Date
HIV ‘gNegative [:1 Positive: _ I, r_ CEA El Negative Cl Positive:

Hep B . E Negative E] Positive: I, " CA 15-3 [1 Negative :1 Positive:

Hep C Wegative C] Positive: I , CA 19-9 :1 Negative El Positive:

AF P D Negative Cl Positive: PSA r3 Negative D Positive:

‘ Other: . . . _

Other. CI Negative D Positive: El Negative El Posmve.
B/T Cell Markers:

 

 

 

' DIAGNOSTIC STUDIES- “'

Results

Ultrasound "
X-

Clinical

Location of Involved L Location of

T N0 M0 Stage: E

 

‘ fTreatment Information!

'SUR' GAL.
Procedure

7

Fri Tumor
Detailed

of Tumor

Nodes
L
Palpable, Non-Dissected Lymph Nodes

Dissected Lymph Nodes
Distant Metastasis

Detailed Location

Distant Metastasis

Date of

 

Date of Procedure

Nodes

 

Pathology Form

 

{Specimen Information]

 

Collected by: ' . . . . Date;_., , _l‘ime:

 

Preserved by: __ __ Date; __

 

 

 
 

    

SBEC-IMEM'EYPE.(##oﬁsamples‘pr’ovid‘ed '

 

 

 

 

 

 

 

 

 

 

Frozen Parafﬁn Block Blood/Serum/Plasma Slide
Diseased Normal Diseased Normal Diseased Normal Diseased Normal
4 .2, 4: 2.. 4 Z ‘
' Time to LN2 Time to Formalin Time to LNZ - '
/,/ min //.Z_ min min :23. -

 

 

 

 

 

OLOGI ' . N .
Tumor
Size Extension of Tumor Distance to NAT

X cm 5‘

Nodes
# Examined # Metastasized

Distant Metastasis
Location

Notes:

 

 

 

{Microscopic Descriptiori

”1.3“:

Cell Distribution

Diffuse

Mosaic

L Inﬁltration
Vascular Invasion
Clusterized

Indian File

4.. -
Cell
Cell
Keratin
Desmosome

Glandular cell
Secretion

Gland formation

Adenomatous

+

Cell Stratiﬁcation

Vacuole

Cellular Differentiation:

Structural Pattern

Storiform
Fibrosis

Sarcomatous + - L
Round Cell
Fibroblast

Osteoblast

Small Cell
RS
Inflam. Cell
Cell
Poor

Like

Well 13 Moderate

 

I“

Nuclear D I I I II

Aniso

Multinucleated Giant Cell
Mitotic
Nuclear Grade:

Marker
ER
PR
Her- neu
B—Cell Marker
T-Cell Marker
Other:
Other:

13 Positive
l:l Positive
D Positive
III Positive
El Positive
a Positive
D Positive

 

 

lﬁnal Pathology Report!

 

 

 

 

 

 

507W}
Histological Diagnosis: [936721912 mwbﬂ (gab/2 may? 02% .7742 é/cm/é/eae
I 1’ . A
Grade. A
Comments:
Date

 

Principal Investigator Pathologist

. . CONSOLIDATED DIAGNOSTIC PATHOLOGY FORM“ -
Microscopic Appearance:

1.
CELL

Diffuse

L
V Invasion
Clustering:

n" Wciﬁcadon
2. Cellular
+ ' + -
cell Round Cell
Cell Cell Stratiﬁcation
Keratin Secretion
Desnlosonle
Pearl Gland
Otllenme Speciﬁed. 7, 7 D],

    

2. Cellular Di enmiatiou: i
Well Moderately Roi

 

 

 

 

 

 

 

Nuclear

 

 

 

Nuclear
5079/3
I gig lgﬂﬂ at W @‘2
Histological Diagnosis: 2 J’ 694/7 {bi/£0 _f
Comments;
“" "“Bue'

.‘u—n—

Dm“. R :-_- a v, - Palm‘m

Rm USE ON.”-
arcommumkmo ”1701,0615! “Wm
rornuomr-‘S

#(mrEmATED REFOR

